Actinium Pharmaceuticals
ATNM
ATNM
62 hedge funds and large institutions have $7.66M invested in Actinium Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
42% less capital invested
Capital invested by funds: $13.2M → $7.66M (-$5.53M)
50% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 22
Holders
62
Holding in Top 10
–
Calls
$99K
Puts
$1K
Top Buyers
| 1 | +$929K | |
| 2 | +$306K | |
| 3 | +$213K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$137K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$90.9K |
Top Sellers
| 1 | -$2.07M | |
| 2 | -$592K | |
| 3 | -$535K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$519K |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
-$376K |
